What’s New in 2025 HIV Treatments: Breakthroughs & Hope
Discover the newest HIV treatments of 2025 including long-acting injectables like lenacapavir and cure research progress.
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV ...
Jun 18, 2025 · Gilead researchers have developed 13 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help reduce new …
FDA approves new HIV drug offering 100% protection
Jul 26, 2025 · In the US, the Food and Drug Administration (FDA) has approved the novel lenacapavir – sold under the brand name Yeztugo – a class of drugs known as capsid inhibitors, which provide …
The Science Moving HIV Cures Forward: A Look at NPRC’s Most …
Dec 22, 2025 · Because the drug is already FDA-approved for use in cancer patients, it could accelerate potential approval for TB/HIV treatment compared to developing an entirely new drug. A Path …
New HIV Treatments on the Horizon - WebMD
Jan 30, 2025 · After major advances in HIV treatment over the last 25 years, new drugs and experimental treatments in the pipeline may bring more improvements to care.
New long-acting HIV drugs show promising early results
Mar 17, 2025 · Drug companies are competing to develop long-acting treatments so that people with HIV do not have to take pills every day and the new drugs presented this week at CROI 2025 each …
New Data on HIV-1 Treatments, Including Biktarvy and Novel …
Mar 19, 2025 · Results highlight promising advancements in novel treatments for patients with HIV-1, including a combination regimen with broadly neutralizing antibodies and long-term data on …
New HIV Treatment Guidelines 2025: What Patients Need to Know
With the release of HIV treatment guidelines 2025, patients and providers face critical changes in prevention, therapy, and care strategies. These updates reflect years of new research, the approval …
Groundbreaking Twice-Yearly HIV Prevention Injection Approved by FDA
Jun 26, 2025 · In 2022, Gilead Sciences, Inc., received U.S. Food and Drug Administration (FDA) approval for lenacapavir, a twice-yearly injectable medication for adults with multidrug-resistant HIV.
The Road to Lenacapavir, a Breakthrough HIV Treatment
May 8, 2025 · Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on HIV’s cone-shaped capsid protein, gets close, almost …